# DBTL Multi-Agent Lab — Real Cycle Output
Model: claude-sonnet-4-6 | Dataset: data/dave-plots/summary_stats.csv
Objective: Optimize an n4 SRT–mCherry reporter library; flag undefined/anomalous tokens with confidence.


================================================================
## DESIGN PHASE
================================================================

# Design Phase Specification: SRT–mCherry Reporter Library Optimization in *E. coli*

---

## 0. Clarifying Assumptions (Flag for Review)

Before proceeding, I note the following ambiguities. If any are incorrect, please revise before Build begins.

| # | Assumption | Confidence | Action if Wrong |
|---|---|---|---|
| A1 | "n4 SRT" = a tetrameric repeat of the SRT consensus peptide fused N-terminally to mCherry | 0.65 | Redefine fusion architecture |
| A2 | Library varies codon usage (CAI axis) and 5′-UTR structure (ΔG folding axis) | 0.80 | Expand or collapse design axes |
| A3 | Single-plasmid, constitutive or inducible (e.g., T7/lac) promoter in BL21(DE3) or similar | 0.75 | Adjust RBS/promoter tier |
| A4 | "Around one DBTL cycle" = ~2–3 weeks total Build+Test time, so library size ≤ 96 constructs | 0.85 | Scale library up/down |
| A5 | FACS gates (Low/Med/High) are pre-defined by instrument team; fluorescence-per-OD is the primary fitness proxy | 0.90 | Re-calibrate gate thresholds |
| A6 | mCherry maturation time is accounted for in timepoint selection | 0.70 | Add maturation correction factor |

---

## 1. Design Axes and Feature Space

### 1.1 Primary Design Variables

```
┌─────────────────────────────────────────────────────────────────┐
│  DESIGN SPACE (2D primary + 1D secondary)                       │
│                                                                  │
│  Axis 1 — Codon Adaptation Index (CAI): 0.60 → 0.95            │
│           5 tiers: 0.60 | 0.70 | 0.80 | 0.88 | 0.95           │
│                                                                  │
│  Axis 2 — 5′-UTR ΔG (RNA folding, kcal/mol): −15 → +2         │
│           4 tiers: −15 | −8 | −3 | +1                          │
│                                                                  │
│  Axis 3 (secondary) — SRT linker flexibility: rigid | flexible  │
│           rigid  = (EAAAK)×2                                    │
│           flexible = (GGGGS)×3                                  │
└─────────────────────────────────────────────────────────────────┘
```

### 1.2 Construct Architecture

```
5′-[Promoter]─[5′-UTR / RBS]─[ATG]─[n4-SRT]─[Linker]─[mCherry]─[Stop]─[Terminator]-3′
        │            │                   │         │         │
     T7lac       variable ΔG        fixed seq  Axis 3    fixed seq
     (fixed)      (Axis 2)          (codon     variable  (codon opt.
                                    Axis 1)              fixed, CAI≥0.92)
```

**Key constraint:** mCherry sequence is held at CAI ≥ 0.92 and fixed across all variants to isolate SRT-region effects on expression.

---

## 2. Design Candidates (Numbered, Prioritized)

### Design Candidate 1 — Positive Control (Baseline)
**Priority: HIGHEST (anchor for normalization)**

| Parameter | Value |
|---|---|
| CAI (SRT region) | 0.92 (fully E. coli optimized) |
| 5′-UTR ΔG | −8 kcal/mol (moderate, Shine-Dalgarno optimal) |
| Linker | (GGGGS)×3 flexible |
| Rationale | Mirrors literature best-practice; establishes fluorescence ceiling |
| Expected FACS gate | High (>75% events) at 4 h post-induction |
| n = | 3 biological replicates |

---

### Design Candidate 2 — Full CAI Ladder (Constant UTR)
**Priority: HIGH (resolves CAI effect cleanly)**

5 constructs, one per CAI tier, UTR fixed at ΔG = −8 kcal/mol, linker = flexible.

| Construct ID | CAI | Expected Gate Shift |
|---|---|---|
| CAI-060 | 0.60 | Low |
| CAI-070 | 0.70 | Low→Medium |
| CAI-080 | 0.80 | Medium |
| CAI-088 | 0.88 | Medium→High |
| CAI-095 | 0.95 | High |

**Rationale:** Rare codons in SRT region may stall ribosomes; CAI ladder will reveal stalling threshold. CAI > 0.88 expected to saturate expression given typical E. coli translation resources.

**Assumption:** Codon usage table from *E. coli* K-12 MG1655 (GenBank U00096); flag if strain differs.

---

### Design Candidate 3 — Full UTR ΔG Ladder (Constant CAI)
**Priority: HIGH (resolves 5′-UTR folding effect)**

4 constructs, CAI fixed at 0.88, linker = flexible.

| Construct ID | ΔG (kcal/mol) | Predicted Effect |
|---|---|---|
| UTR-m15 | −15 | Over-accessible; possible read-through artifacts |
| UTR-m08 | −8 | Optimal SD exposure |
| UTR-m03 | −3 | Moderate hairpin, reduced translation initiation |
| UTR-p01 | +1 | Strong hairpin, near-zero translation expected |

**Rationale:** RNA secondary structure at the RBS is frequently the dominant expression bottleneck; this ladder isolates that variable.

---

### Design Candidate 4 — Full 2D Matrix (Core Experimental Block)
**Priority: HIGH (main dataset)**

5 CAI tiers × 4 UTR tiers = **20 constructs**, both linker variants = **40 constructs total**.

```
         CAI
ΔG    0.60  0.70  0.80  0.88  0.95
−15   [4a]  [4b]  [4c]  [4d]  [4e]
 −8   [4f]  [4g]  [4h]  [4i]  [4j]   ← Design 2 & 3 overlap here
 −3   [4k]  [4l]  [4m]  [4n]  [4o]
 +1   [4p]  [4q]  [4r]  [4s]  [4t]
```

Each cell exists in flexible AND rigid linker variant. **Total: 40 constructs.**

**Rationale:** Interaction effects between CAI and UTR ΔG are expected (e.g., ribosome pausing may be rescued by more accessible UTR); the 2D matrix captures epistasis.

---

### Design Candidate 5 — Negative Controls
**Priority: HIGHEST (essential for gating calibration)**

| Construct ID | Description | Purpose |
|---|---|---|
| NEG-noSRT | mCherry alone, no SRT, CAI 0.92 | Fusion penalty baseline |
| NEG-stop | Premature stop in SRT, CAI 0.88 | Truncation artifact detection |
| NEG-noFP | n4-SRT only, no mCherry | Autofluorescence background |
| NEG-empty | Empty vector | Instrument/media background |

---

### Design Candidate 6 — Anomalous-Token Sentinel Constructs
**Priority: MEDIUM (supports Learn-phase QC)**

These constructs deliberately introduce features that the Learn module should flag:

| Construct ID | Anomaly Introduced | Learn-phase Flag Expected |
|---|---|---|
| SENT-dupRBS | Duplicated RBS sequence (tandem SD) | Duplicate token / anomalous ΔG |
| SENT-ambigCodon | 3× NNN degenerate codons in SRT | Undefined codon token |
| SENT-frameshift | +1 frameshift at position 12 of SRT | Anomalous CAI drop + stop codon token |
| SENT-highCAI-hairpin | CAI 0.95 + UTR ΔG +1 (extreme combination) | Outlier in 2D feature space |

**Rationale:** Validates the Learn-phase confidence index machinery. If SENT constructs are not flagged, the QC pipeline needs recalibration before the next DBTL cycle.

---

### Design Candidate 7 — Timepoint Expansion Set (Expression Kinetics)
**Priority: MEDIUM**

Take the 5 highest-performing constructs from the 2D matrix (identified after initial FACS sort) and measure at **5 timepoints**: 1 h, 2 h, 4 h, 6 h, 18 h post-induction.

**Rationale:** mCherry maturation (~40 min half-time) means early timepoints underreport actual expression; kinetic data corrects this and informs the Learn model on temporal dynamics.

---

## 3. Sequence-Level Specifications

### 3.1 SRT Consensus Repeat Unit
```
Amino acid (n1 unit):  GPGGYGPGGPG  [canonical SRT β-sheet motif]
n4 repeat:             (GPGGYGPGGPG)×4
Length:                44 aa (SRT) + linker + mCherry (~236 aa) = ~280 aa total
```

### 3.2 Codon Optimization Tool
- **Tool:** COOL (Codon Optimization OnLine) or IDT Codon Optimization, constrained to target CAI
- **Forbidden sequences:** BsaI, BsmBI, SpeI, XbaI restriction sites (for Golden Gate compatibility)
- **GC content bounds:** 40–60% per 30-nt window

### 3.3 5′-UTR Design
```
Fixed promoter → [variable spacer 15–40 nt] → [SD core: AGGAG] → [spacer 5–8 nt] → ATG
                        ↑
               Mutagenize this region to tune ΔG
               Use Mfold/RNAfold at 37°C, ionic strength 1M NaCl
```

ΔG calculated over the window: −30 nt upstream of AUG to +15 nt downstream.

---

## 4. Build Phase Instructions

### 4.1 Synthesis & Cloning Strategy

```
RECOMMENDED: Golden Gate Assembly (BsaI)
  - Order as synthetic gBlocks (≤500 bp each)
  - Destination vector: pET-28a backbone (or equivalent)
  - Insert: [BsaI-site]─[5′-UTR]─[SRT-codon-variant]─[Linker]─[mCherry]─[BsaI-site]
  - Verify: Sanger sequencing of all 96 constructs prior to transformation
```

### 4.2 Plate Layout (96-well format)

```
Rows A–D: Design Candidate 4 (2D matrix, flexible linker), n=1 each
Rows E–H: Design Candidate 4 (2D matrix, rigid linker), n=1 each
Columns 11–12: Controls (Design 5) and Sentinels (Design 6), n=2 each
```

### 4.3 Expression Protocol
- **Host:** BL21(DE3) or Rosetta2 (flag if different)
- **Induction:** 

[TRUNCATED] Output stopped at the 3000-token limit (stop_reason=max_tokens); the answer above may be incomplete. Raise DBTL_MAX_TOKENS to get the full response.
================================================================
## BUILD PHASE
================================================================

# Build Phase Plan: SRT–mCherry Reporter Library in *E. coli*

---

## Build Phase Overview

This plan converts the Design Phase specification into a concrete, reproducible construction workflow for **up to 96 constructs** across 7 design candidates. All steps are scoped for a **14-day build window** targeting single-cycle completion.

---

## 1. Parts List and Reagents

### 1.1 Synthetic DNA Parts (Ordered from Vendor)

All inserts ordered as **IDT gBlocks or Twist Synthetic Fragments** (≤500 bp each). Forbidden sites (BsaI, BsmBI, SpeI, XbaI) are computationally scrubbed before ordering.

| Part ID | Description | Length (approx.) | Quantity | Notes |
|---|---|---|---|---|
| VEC-pET28a-BsaI | pET-28a backbone, BsaI Golden Gate–adapted, kanamycin-resistant | 5.4 kb | 1 prep (>1 µg) | Pre-digested and gel-purified; store at −20°C |
| SRT-n4-CAI060 through CAI095 | n4-SRT codon variants, 5 tiers | ~132 bp each | 5 oligo/gBlock sets | GC 40–60%; confirmed no internal BsaI |
| UTR-m15, m08, m03, p01 | 5′-UTR spacer variants | 15–40 bp each | 4 synthetic oligo duplexes | ΔG verified by RNAfold at 37 °C prior to ordering |
| LINK-flex | (GGGGS)×3 linker sequence | 45 bp | 1 gBlock or oligo duplex | |
| LINK-rigid | (EAAAK)×2 linker sequence | 30 bp | 1 gBlock or oligo duplex | |
| mCherry-opt | mCherry, CAI ≥ 0.92, fixed | ~711 bp | 1 gBlock | Identical across all constructs |
| CTRL-noSRT | mCherry only, CAI 0.92 | ~750 bp | 1 gBlock | NEG-noSRT |
| CTRL-stop | SRT with premature stop at codon 8 | ~132 bp | 1 gBlock | NEG-stop |
| CTRL-noFP | n4-SRT only, no mCherry | ~180 bp | 1 gBlock | NEG-noFP |
| CTRL-empty | Empty vector insert (stuffer) | ~50 bp | Synthetic oligo duplex | NEG-empty |
| SENT-dupRBS | Tandem SD duplication construct | ~160 bp | 1 gBlock | SENT-dupRBS |
| SENT-ambigCodon | 3× NNN degenerate codons in SRT | ~132 bp | Degenerate pool oligo | SENT-ambigCodon |
| SENT-frameshift | +1 frameshift at SRT position 12 | ~132 bp | 1 gBlock | SENT-frameshift |
| SENT-highCAI-hairpin | CAI 0.95 + UTR ΔG +1 | Full insert ~900 bp | 1 gBlock | SENT-highCAI-hairpin |

> **⚠ Practical Flag — SENT-ambigCodon:** NNN degenerate codons cannot be specified as a single gBlock sequence. Order as a degenerate oligo pool (phosphorylated, PAGE-purified) and clone separately. Anticipated failure point: sequencing will show mixed traces; accept if ≥1 NNN position is confirmed ambiguous. Mark sample metadata accordingly.

### 1.2 Enzymes and Reagents

| Reagent | Supplier (Example) | Amount | Storage |
|---|---|---|---|
| BsaI-HFv2 | NEB R3733 | 1 vial | −20°C |
| T4 DNA Ligase (2000 U/µL) | NEB M0202 | 1 vial | −20°C |
| Q5 Hot Start Master Mix | NEB M0494 | 2 × 1 mL | −20°C |
| DpnI | NEB R0176 | 1 vial | −20°C |
| Phusion Flash PCR MM | ThermoFisher | Optional backup | −20°C |
| Monarch PCR & DNA Cleanup Kit | NEB T1030 | 1 kit | RT |
| Monarch Gel Extraction Kit | NEB T1020 | 1 kit | RT |
| T4 Polynucleotide Kinase | NEB M0201 | 1 vial | −20°C |
| NEB 10-beta competent cells | NEB C3019 | 4 × 0.5 mL tubes | −80°C (cloning) |
| BL21(DE3) competent cells | NEB C2527 | 6 × 0.5 mL tubes | −80°C (expression) |
| LB Broth (powder) | Sigma | 500 g | RT |
| Kanamycin (50 mg/mL stock) | Sigma | 10 mL | −20°C |
| IPTG (1 M stock, filter-sterilized) | Goldbio | 5 mL | −20°C |
| 96-well deep-well plates (2 mL) | Axygen | 4 plates | RT |
| 96-well flat-bottom plates (black, clear bottom) | Corning 3603 | 2 plates | RT |
| Breathe-Easy sealing membrane | Sigma Z763624 | 1 roll | RT |
| PBS pH 7.4, sterile | Gibco | 500 mL | RT |

---

## 2. Assembly Strategy: One-Pot Golden Gate

### 2.1 Modular Insert Architecture

Each full insert is assembled from 3 modules in a single Golden Gate reaction:

```
Module A          Module B          Module C
[5′-UTR/RBS]  +  [n4-SRT-codon]  +  [Linker + mCherry]
   15–40 bp         ~132 bp           ~756 bp
   oligo dup        gBlock            gBlock (fixed)

Overhang design (4-nt BsaI-generated):
5′-AATG ─ Module A ─ GCTA | GCTA ─ Module B ─ TTAG | TTAG ─ Module C ─ CCAG-3′
                              ↑                        ↑
                         internal junctions       vector junction
```

> **Rationale for modularity:** mCherry (Module C) is synthesized once and shared across all 40 × 2-linker = 80 constructs, reducing cost. UTR oligo duplexes (Module A) are paired combinatorially with SRT gBlocks (Module B). This yields 5 CAI × 4 UTR × 2 linker = 40 distinct inserts from 5 + 4 + 2 + 1 = 12 unique part types.

### 2.2 Overhang Compatibility Check

Before ordering, verify all 4-nt overhangs using the **NEB Golden Gate Fidelity Tool** (free, web-based). Reject any overhang set with predicted ligation fidelity < 95% or with cross-reactivity between junctions.

| Junction | 4-nt Overhang | Cross-reactivity Check |
|---|---|---|
| Vector 5′ → Module A | AATG | Must differ by ≥2 nt from all others |
| Module A → Module B | GCTA | Verify |
| Module B → Module C | TTAG | Verify |
| Module C → Vector 3′ | CCAG | Must differ by ≥2 nt from all others |

> **⚠ Failure Point:** If any two overhangs differ by only 1 nt, redesign the internal junction sequences in Module A or B before synthesis.

---

## 3. Step-by-Step Protocol

### Phase 1: Part Preparation (Days 1–3)

**Day 1 — Oligo Duplex Annealing (UTR Modules A)**

```
Per UTR variant (4 reactions):
  - 10 µL each oligo (100 µM stock) + 2 µL 10× T4 Ligase Buffer + 78 µL nuclease-free H₂O
  - T4 PNK phosphorylation: 37°C, 30 min; 65°C, 20 min inactivation
  - Annealing: 95°C → ramp to 25°C at −0.1°C/s in thermocycler
  - Store at −20°C; label as UTR-m15-A, UTR-m08-A, UTR-m03-A, UTR-p01-A
```

**Day 1–2 — Resuspend and QC Synthetic gBlocks**

```
  - Resuspend each gBlock per IDT instructions (target: 10 ng/µL working stock)
  - Run 1 µL on TapeStation D1000 or 2% agarose gel to confirm size
  - Nanodrop/Qubit quantification; flag any gBlock with yield < 100 ng
  - If gBlock fails QC: re-order immediately (do not proceed to assembly)
```

**Day 2–3 — Vector Preparation**

```
  - Miniprep pET-28a-BsaI from glycerol stock
  - BsaI-HFv2 digestion: 37°C, 1 h; 80°C, 20 min heat-kill
  - Gel-purify linearized vector (0.8% agarose, Monarch kit)
  - Elute in 30 µL nuclease-free H₂O; Qubit quantify
  - Target: ≥20 ng/µL; store at −20°C
  - Label: VEC-pET28a-BsaI-linearized-YYYYMMDD
```

---

### Phase 2: Golden Gate Assembly (Day 3–4)

**Reaction Setup (96-well plate format, one reaction per construct)**

```
Component                        Volume per reaction
─────────────────────────────────────────────────────
Vector (linearized, 20 ng/µL)      1 µL  (20 ng)
Module A (UTR oligo duplex, 10 nM) 1 µL
Module B (SRT gBlock, 10 ng/µL)    1 µL
Module C (mCherry gBlock, 10 ng/µL)1 µL  [shared master stock]
T4 DNA Ligase Buffer (10×)         1 µL
BsaI-HFv2 (10 U/µL)               0.5 µL
T4 DNA Ligase (400 U/µL)           0.5 µL
Nuclease-free H₂O                  4 µL
─────────────────────────────────────────────────────
Total                              10 µL
```

**Thermocycler Program:**

```
Step 1: 37°C × 1 min   ┐
Step 2: 16°C × 1 min   ├ × 30 cycles
Step 3: 37°C × 5 min   (final BsaI digest)
Step 4: 65°C × 5 min   (heat-kill BsaI and ligase)
Step 5:  4°C  hold
```

**Plate Map for Assembly Reactions:**

```
       Col 1  Col 2  Col 3  Col 4  Col 5  Col 6  Col 7  Col 8  Col 9  Col

[TRUNCATED] Output stopped at the 3000-token limit (stop_reason=max_tokens); the answer above may be incomplete. Raise DBTL_MAX_TOKENS to get the full response.
================================================================
## TEST PHASE
================================================================

# Test Phase Plan & Dataset Report
## SRT–mCherry Reporter Library in *E. coli* | DBTL Cycle 1

---

## SECTION 1 — TESTING PLAN

### 1.1 Measurement Objectives

| # | Objective | Assay |
|---|---|---|
| 1 | Quantify mCherry fluorescence as proxy for SRT-fusion expression | FACS + plate-reader OD normalization |
| 2 | Resolve construct distribution across expression tiers | FACS gate sorting (Low / Medium / High) |
| 3 | Capture kinetics of expression | Three timepoints post-induction |
| 4 | Associate sequence features (CAI, RNA ΔG) with expression output | Metadata join on construct ID |
| 5 | Detect non-expressing, misfiring, or toxic constructs | Sentinel controls in every plate |

---

### 1.2 Assay Specifications

#### 1.2.1 Growth and Induction Protocol

| Parameter | Specification |
|---|---|
| Host strain | BL21(DE3) |
| Media | LB + 50 µg/mL kanamycin |
| Pre-culture | 37 °C, 250 rpm, overnight from glycerol stock |
| Inoculation | 1:100 dilution into 1 mL LB-kan in 96-well deep-well plate |
| Growth to induction | 37 °C, 900 rpm (deep-well thermoshaker) until OD₆₀₀ ≈ 0.4–0.6 (~2.5 h) |
| IPTG induction | 0.5 mM final concentration |
| Post-induction temperature | 30 °C (reduces inclusion body formation) |
| **Measurement timepoints** | **T = 15 h, 25 h, 35 h post-induction** |
| Sample volume per timepoint | 200 µL removed; pellet remainder for archival |

#### 1.2.2 FACS Measurement

| Parameter | Specification |
|---|---|
| Instrument | BD FACSAria III (or equivalent sorter with 561 nm laser) |
| Excitation | 561 nm |
| Emission filter | 610/20 nm bandpass (mCherry) |
| Forward scatter | FSC-A (size gate: exclude debris < 0.2 µm equivalent) |
| Side scatter | SSC-A |
| Doublet exclusion | FSC-H vs FSC-A singlet gate |
| Events per sample | ≥ 10,000 singlet events minimum; target 15,000–18,000 |
| Sample prep | Pellet 200 µL culture (3,000 × g, 5 min); resuspend in 1× PBS pH 7.4 to OD₆₀₀ ≈ 0.1 |
| Controls run first | NEG-empty (autofluorescence baseline), CTRL-noFP (background), CTRL-noSRT (maximum mCherry) |

**Gate Definitions (set from controls at T = 15 h; held constant across all timepoints):**

| Gate Label | Fluorescence Range | Setting Basis |
|---|---|---|
| Low | Bottom tertile of control-normalized distribution | ≤ 33rd percentile at T=15 h across all constructs |
| Medium | Middle tertile | 34th–66th percentile |
| High | Top tertile | ≥ 67th percentile |

> ⚠ **Gate lock requirement:** Gates are defined once from T = 15 h data and applied unchanged to T = 25 h and T = 35 h. Any drift in instrument laser power must be corrected by daily calibration beads (e.g., Spherotech Rainbow beads) before each session.

#### 1.2.3 OD₆₀₀ Normalization

| Parameter | Specification |
|---|---|
| Instrument | Plate reader (e.g., BioTek Synergy H1) |
| Wavelength | 600 nm, path-length correction ON (200 µL in Corning 3603) |
| Blanks | LB + kanamycin (no cells), run in triplicate per plate |
| Fluorescence read | 560 nm excitation / 610 nm emission, gain optimized on CTRL-noSRT |
| Metric reported | `fluor_per_od` = (RFU − blank RFU) / (OD₆₀₀ − blank OD₆₀₀) |

#### 1.2.4 Sequence Feature Computation

| Feature | Tool | Version | Notes |
|---|---|---|---|
| CAI | CAIcal or CodonW | ≥1.0 | Computed against *E. coli* K-12 codon table |
| `dG_cds_only` | RNAfold (ViennaRNA) | ≥2.6 | Full CDS folding, 37 °C, no pseudoknots |
| `dG_junction` | RNAfold | ≥2.6 | 30 nt upstream + 30 nt downstream of SRT–mCherry junction |
| `dG_utr_cds30` | RNAfold | ≥2.6 | 5′-UTR + first 30 nt of CDS window |

---

### 1.3 Replicates and Statistical Power

| Level | N | Rationale |
|---|---|---|
| Biological replicates | 3 independent cultures per construct per timepoint | Minimum for variance estimation |
| Technical replicates (plate reader) | 2 reads per well per timepoint | Instrument CV check |
| Positive control replicates | CTRL-noSRT in 4 wells per plate | Plate-to-plate normalization anchor |
| Negative control replicates | NEG-empty in 4 wells per plate | Autofluorescence subtraction anchor |
| FACS capillaries | ≥ 10,000 events per sample (target ~17,000 per bin row as observed) | Sufficient for gate statistics |

---

### 1.4 Quality-Control Checks

| QC Check | Criterion | Action if Failed |
|---|---|---|
| Calibration beads CV | ≤ 5% CV on bead reference channel | Abort session; recalibrate instrument |
| Negative control autofluorescence | NEG-empty RFU < 5% of CTRL-noSRT RFU | Investigate media/plate fluorescence; replace consumables |
| OD at induction (T=0) | OD₆₀₀ 0.4–0.6 ± 0.1 | Flag wells outside range; exclude from analysis |
| Plate-reader blank CV | < 3% CV across blank wells | Re-read plate; check evaporation |
| Positive control consistency | CTRL-noSRT `fluor_per_od` within 15% across plates | Normalize plate data to CTRL-noSRT median if 15–25%; exclude plate if > 25% |
| Sentinel SENT-frameshift | Must fall in Low bin | If in Medium/High: gate calibration error; re-gate |
| Sentinel SENT-dupRBS | Must fall in High bin | If in Low/Medium: induction failure or construct error |
| Sequencing confirmation | >90% of constructs confirmed by Sanger (T7 primer + internal) | Flag unconfirmed constructs in metadata; exclude from primary model |
| n_capillaries per bin | ≥ 10,000 events | Flag bin; deprioritize in Learn phase regression |
| `fluor_per_od_std` / `fluor_per_od_mean` (CV) | < 60% | Flag as high-variance; check for bimodal population |

---

## SECTION 2 — DATASET SCHEMA

### 2.1 Controlled Vocabulary

#### `bin` column
| Token | Definition |
|---|---|
| `Low` | Constructs sorted into bottom fluorescence tertile gate |
| `Medium` | Constructs sorted into middle fluorescence tertile gate |
| `High` | Constructs sorted into top fluorescence tertile gate |

> No other values are permitted. Any other string (e.g., `low`, `HIGH`, `None`, `NA`) is an **undefined token** and must be flagged.

#### `timepoint_h` column
| Permitted Values | Definition |
|---|---|
| `15`, `25`, `35` | Hours post-IPTG induction |

> Values outside {15, 25, 35} are **anomalous tokens**.

---

### 2.2 Full Column Schema

| Column | Type | Units | Expected Range | Notes |
|---|---|---|---|---|
| `bin` | categorical | — | {Low, Medium, High} | Controlled vocabulary; 3-class gate label |
| `timepoint_h` | integer | hours | {15, 25, 35} | Discrete; 3 permitted values only |
| `n_capillaries` | integer | event count | 10,000–20,000 | Below 10,000 → low-confidence flag |
| `cai_mean` | float | dimensionless | 0.0–1.0 (expected 0.60–0.96) | Mean Codon Adaptation Index across bin members |
| `cai_std` | float | dimensionless | 0.0–0.15 | SD of CAI within bin |
| `fluor_per_od_mean` | float | RFU / OD₆₀₀ | 0–2000 (library expected 50–600) | Mean fluorescence normalized to OD |
| `fluor_per_od_std` | float | RFU / OD₆₀₀ | 0–600 | SD within bin; CV > 60% → high-variance flag |
| `dG_dG_cds_only` | float | kcal/mol | −30 to 0 | RNAfold ΔG for full CDS; **column name anomaly — see Section 3** |
| `ra_dG_cds_only` | float | kcal/mol | −30 to 0 | **Column name anomaly — see Section 3** |
| `dG_junction` | float | kcal/mol | −15 to 0 | ΔG at SRT–mCherry junction ±30 nt |
| `dG_utr_cds30` | float | kcal/mol | −20 to 0 | ΔG of 5′-UTR + first 30 nt CDS window |

---

## SECTION 3 — DATASET SUMMARY & ANOMALY REPORT

### 3.1 Structural Summary

| Property | Value |
|---|---|
| File | `summary_stats.csv` |
| Rows | 9 (3 bins × 3 timepoints — complete factorial) |
| Columns | 11 |
| Missing values | **0** (all cells populated) |
| Duplicate rows | **0** detected |
| Unique (bin, timepoint_h) combinations | 9 — fully crossed, no missing cells |

---

### 3.2 Flagged Anomalies and Confidence Index

> **Confidence Index (CI)** is rated 0–1 where 1.0 = certain error requiring correction before Learn phase ingestion, and lower values = suspected issue warranting review.

---

#### 🔴 FLAG 1 — Duplicate/Redundant Column: `dG_dG_cds_only` vs `ra_dG_cds_only`
| Property | Detail |
|---|---|
| **Columns affected** | `dG_dG_cds_only`, `ra_dG_cds_only` |
| **Observation** | Both columns carry identical values across all 9 rows: (−12.4, −11.9, −11.6) repeating by bin group |
| **Anomaly type** | Duplicate feature

[TRUNCATED] Output stopped at the 3000-token limit (stop_reason=max_tokens); the answer above may be incomplete. Raise DBTL_MAX_TOKENS to get the full response.
================================================================
## LEARN PHASE (full)
================================================================

# Learn Phase Report — DBTL Cycle 1
## SRT–mCherry Reporter Library | *E. coli* BL21(DE3)

---

## 0. METHODOLOGY OVERVIEW

### Confidence Index (CI) Definition

All flags are scored on a **CI scale of 0.0–1.0**:

| CI Range | Interpretation | Required Action |
|---|---|---|
| 0.90–1.00 | Certain error / confirmed anomaly | **Must resolve before Learn-phase model ingestion** |
| 0.70–0.89 | High-confidence issue | Strong recommendation to resolve; flag in model |
| 0.50–0.69 | Probable issue | Investigate; include as covariate uncertainty |
| 0.30–0.49 | Possible issue | Document; monitor in next cycle |
| 0.00–0.29 | Low suspicion | Note only |

### CI Computation Formula

For each flag *f*, CI is computed as a weighted sum:

```
CI_f = w1·(cardinality_signal) + w2·(schema_violation_signal) + w3·(biological_plausibility_signal) + w4·(reproducibility_signal)
```

Where weights sum to 1.0 and each signal is 0 or 1 (or fractional for partial evidence). Specific weights are stated per flag below.

---

## 1. STRUCTURAL INTEGRITY CHECKS

### 1.1 Dataset Dimensions

| Property | Observed | Expected | Status |
|---|---|---|---|
| Rows | 9 | 9 (3 bins × 3 timepoints) | ✅ PASS |
| Columns | 11 | 9 (per canonical schema) | ⚠️ EXCESS (+2 suspicious) |
| Missing values | 0 | 0 | ✅ PASS |
| Duplicate rows | 0 | 0 | ✅ PASS |
| Unique (bin, timepoint_h) combos | 9 | 9 | ✅ PASS |
| `bin` vocabulary | {Low, Medium, High} | {Low, Medium, High} | ✅ PASS |
| `timepoint_h` vocabulary | {15, 25, 35} | {15, 25, 35} | ✅ PASS |

---

## 2. FLAG REGISTER

---

### 🔴 FLAG 1 — Undefined / Malformed Column Token: `dG_dG_cds_only`

**Category:** Undefined token (column name) — prefix duplication artefact

| Property | Detail |
|---|---|
| **Column observed** | `dG_dG_cds_only` |
| **Expected token** | `dG_cds_only` (per Section 2.2 of schema) |
| **Anomaly type** | Column name contains doubled prefix `dG_` + `dG_` → likely a pipeline concatenation error (e.g., `prefix + column_name` where column_name itself already contained `dG_`) |
| **Cardinality** | 3 unique values: {−12.4, −11.9, −11.6}, each repeated 3× |
| **Value range** | −12.4 to −11.6 kcal/mol — within schema expectation (−30 to 0) |
| **Rows affected** | All 9 / 9 (100%) |

**CI Computation:**

| Signal | Weight | Value | Contribution |
|---|---|---|---|
| `cardinality_signal`: values exist and are non-null (not pure noise) | 0.20 | 1.0 | 0.20 |
| `schema_violation_signal`: name ≠ any permitted column token | 0.40 | 1.0 | 0.40 |
| `biological_plausibility_signal`: values plausible for ΔG_CDS (within −30 to 0 range) | 0.20 | 0.0 | 0.00 (plausible → not noise) |
| `reproducibility_signal`: identical to `ra_dG_cds_only` (confirmed duplicate content) | 0.20 | 1.0 | 0.20 |
| **CI_FLAG1** | | | **0.80** |

> **CI = 0.80 — HIGH CONFIDENCE: Malformed column token requiring rename before model ingestion.**

**Root cause hypothesis:** Automated feature-extraction pipeline applied a `dG_` prefix to a column already named `dG_cds_only`, producing `dG_dG_cds_only`. Probability: ~85%.

**Required action:** Rename `dG_dG_cds_only` → `dG_cds_only` after resolving FLAG 2 (deduplication decision).

---

### 🔴 FLAG 2 — Undefined / Redundant Column Token: `ra_dG_cds_only`

**Category:** Undefined token (column name) — unrecognized prefix, content-duplicate of FLAG 1

| Property | Detail |
|---|---|
| **Column observed** | `ra_dG_cds_only` |
| **Expected token** | No `ra_` prefix defined in schema; nearest match is `dG_cds_only` |
| **Anomaly type** | Unknown prefix `ra_`; not in controlled vocabulary. Possible origins: (a) tool-specific prefix from an RNA analysis wrapper (`ra` = "RNA analysis"?), (b) leftover branch column from a pipeline fork, (c) typographic corruption of `dG_` |
| **Cardinality** | 3 unique values: {−12.4, −11.9, −11.6} — **identical set and pattern to `dG_dG_cds_only`** |
| **Value correlation with `dG_dG_cds_only`** | r = 1.00 (perfect, all 9 rows match exactly) |
| **Rows affected** | All 9 / 9 (100%) |

**CI Computation:**

| Signal | Weight | Value | Contribution |
|---|---|---|---|
| `cardinality_signal`: values exist; non-null; numerically plausible | 0.20 | 1.0 | 0.20 |
| `schema_violation_signal`: `ra_` prefix undefined in any schema section | 0.40 | 1.0 | 0.40 |
| `biological_plausibility_signal`: within valid ΔG range | 0.20 | 0.0 | 0.00 |
| `reproducibility_signal`: perfect duplicate of FLAG 1 column (r=1.00, all rows) | 0.20 | 1.0 | 0.20 |
| **CI_FLAG2** | | | **0.80** |

> **CI = 0.80 — HIGH CONFIDENCE: Undefined column token and content-duplicate. One of {`dG_dG_cds_only`, `ra_dG_cds_only`} must be dropped; the survivor renamed to `dG_cds_only`.**

**Joint diagnosis (FLAGS 1+2):** The pipeline almost certainly exported the same computed feature twice under two erroneous names. The canonical feature is `dG_cds_only`. Recommended resolution: drop `ra_dG_cds_only`, rename `dG_dG_cds_only` → `dG_cds_only`.

---

### 🔴 FLAG 3 — Zero-Variance Column: `dG_junction` (Constant Value)

**Category:** Statistical anomaly — zero variance across all bins and timepoints

| Property | Detail |
|---|---|
| **Column** | `dG_junction` |
| **Unique values** | 1 (−3.1 kcal/mol across all 9 rows) |
| **Expected behavior** | Should vary across bins if different constructs with different junction sequences sort into different gates |
| **Schema expectation** | −15 to 0 kcal/mol range; variation expected |
| **Variance** | σ² = 0.000, CV = undefined (zero SD) |
| **Rows affected** | 9 / 9 (100%) |

**CI Computation:**

| Signal | Weight | Value | Contribution |
|---|---|---|---|
| `cardinality_signal`: single unique value across full factorial — statistically improbable | 0.25 | 1.0 | 0.25 |
| `schema_violation_signal`: value (−3.1) within permitted range; name matches schema exactly | 0.25 | 0.0 | 0.00 |
| `biological_plausibility_signal`: identical junction ΔG across all expression bins is biologically implausible unless all constructs share the exact same junction; partial credit | 0.30 | 0.80 | 0.24 |
| `reproducibility_signal`: zero variance is consistent across all timepoints (not random) | 0.20 | 0.50 | 0.10 |
| **CI_FLAG3** | | | **0.59** |

> **CI = 0.59 — PROBABLE ISSUE: Zero-variance column will contribute zero information to any regression model. Three alternative root causes ranked by probability:**

| Rank | Hypothesis | Est. Probability |
|---|---|---|
| 1 | All library constructs share an identical junction sequence by design (e.g., fixed linker) → feature is truly invariant in this library | 45% |
| 2 | RNAfold computation failed silently; default/fallback value (−3.1) written to all rows | 35% |
| 3 | Bin-level averaging collapsed genuine per-construct variation to a single mean (unlikely if constructs differ) | 20% |

**Required action:** Query the pipeline operator: Is the SRT–mCherry junction sequence fixed across all constructs? If yes, retain column with annotation `[INVARIANT — design feature]` but exclude from feature matrix. If no, recompute `dG_junction` from per-construct sequences.

---

### 🟡 FLAG 4 — Temporal Invariance of RNA Folding Features (`dG_dG_cds_only`, `dG_utr_cds30`)

**Category:** Statistical anomaly — ΔG values constant across timepoints (expected behaviour for sequence-derived features, but worth confirming)

| Property | Detail |
|---|---|
| **Columns** | `dG_dG_cds_only`, `ra_dG_cds_only`, `dG_utr_cds30` |
| **Observation** | Each bin's ΔG value is identical at T=15, T=25, T=35 |
| **Biological expectation** | Sequence-derived thermodynamic features *should* be time-invariant (sequence does not change) — this is **expected** |
| **Risk** | If values were mistakenly copied across timepoints from a single-timepoint computation rather than computed independently, errors would be invisible |

**CI Computation:**

| Signal | Weight | Value | Contribution |
|---|---|---|---|
| `cardinality_signal`: values repeat 3× per bin — consistent with time-invariance expectation | 0.30 | 0.0 | 0.00 |
| `schema_violation_signal`: no schema violation | 0.30 | 0.0 | 0.00 |
| `biological_plausibility_signal`: time-invariant ΔG is expected; low suspicion | 0.20 | 0.20 | 0.04 |
| `reproducibility_signal`: perfectly consistent pattern | 0.20 | 0.10 | 0.02 |
| **CI_FLAG4** | | | **0.06** |

> **CI = 0.06 — LOW SUSPICION: Behaviour is expected for sequence-derived features. Note only; no action required unless provenance of computation is unverified.**

---

### 🟡 FLAG 5 — `cai_std` Cardinality Anomaly (Potential Duplicate Value)

**Category:** Minor statistical anomaly — one value appears twice

| Property | Detail |
|---|---|
| **Column** | `cai_std` |
| **Unique values** | 8 (not 9 as expected for a fully unique set) |
| **Duplicate value** | 0.037 appears in 2 rows |
| **Rows sharing value** | Medium/T=25 (cai_std=0.037) and Medium/T=35 (cai_std=0.037) |
| **Expected** | Mild — SD estimates can coincide by chance; not alarming |

**CI Computation:**

| Signal | Weight | Value | Contribution |
|---|---|---|---|
| `cardinality_signal`: 1 duplicate in 9 values — low signal | 0.40 | 0.20 | 0.08 |
| `schema_violation_signal`: value within range (0–0.15); name correct | 0.30 | 0.0 | 0.00 |
| `biological_plausibility_signal`: CAI SD stabilising across late timepoints is plausible | 0.30 | 0.10 | 0.03 |
| **CI_FLAG5** | | | **0.11** |

> **CI = 0.11 — LOW SUSPICION: Likely genuine coincidence. No action required.**

---

### 🟢 FLAG 6 — CV Check on `fluor_per_od` (QC Criterion: CV < 60%)

**Category:** QC threshold evaluation

Computed CV = `fluor_per_od_std` / `fluor_per_od_mean` × 100% for each row:

| bin | timepoint_h | mean | std | CV (%) | Status |
|---|---|---|---|---|---|
| Low | 15 | 58.3 | 22.1 | **37.9%** | ✅ PASS |
| Medium | 15 | 181.6 | 49.7 | **27.4%** | ✅ PASS |
| High | 15 | 342.8 | 88.2 | **25.7%** | ✅ PASS |
| Low | 25 | 71.5 | 27.4 | **38.3%** | ✅ PASS |
| Medium | 25 | 224.9 | 60.3 | **26.8%** | ✅ PASS |
| High | 25 | 431.2 | 102.6 | **23.8%** | ✅ PASS |
| Low | 35 | 80.2 | 31.0 | **38.7%** | ✅ PASS |
| Medium | 35 | 251.3 | 66.8 | **26.6%** | ✅ PASS |
| High | 35 | 469.7 | 110.4 | **23.5%** | ✅ PASS |

> **All 9 rows PASS the CV < 60% QC criterion. Highest CV is in the Low bin (~38–39%), consistent with noisy low-expressing constructs. No bimodal population flag triggered.**

---

### 🟢 FLAG 7 — `n_capillaries` Range Check (QC Criterion: ≥ 10,000 events)

| Statistic | Value |
|---|---|
| Min | 16,880 |
| Max | 17,250 |
| Mean | 17,053 |
| All rows ≥ 10,000? | ✅ YES |
| All rows ≤ 20,000 (schema max)? | ✅ YES |

> **All 9 rows PASS. Event counts are tightly clustered (range = 370 events, ~2.2% spread), indicating consistent FACS acquisition.**

---

### 🟢 FLAG 8 — `cai_mean` Range and Monotonicity Check

| Observation | Detail |
|---|---|
| Range observed | 0.709–0.761 |
| Schema expectation | 0.60–0.96 |
| Within range? | ✅ YES |
| Monotonic ordering (Low < Medium < High) at each timepoint? | ✅ YES (T=15: 0.712 < 0.744 < 0.758; T=25: 0.710 < 0.746 < 0.760; T=35: 0.709 < 0.747 < 0.761) |
| Biological interpretation | Higher-CAI constructs sorted into higher-expression bins — **consistent with codon optimization hypothesis** |

> **PASS. No anomaly. CAI gradient across bins is a positive signal for the Design phase.**

---

## 3. CONSOLIDATED FLAG REGISTER

| Flag | Column(s) | Category | CI | Priority | Action Required |
|---|---|---|---|---|---|
| 🔴 FLAG 1 | `dG_dG_cds_only` | Undefined token — malformed column name | **0.80** | CRITICAL | Rename → `dG_cds_only` after FLAG 2 resolution |
| 🔴 FLAG 2 | `ra_dG_cds_only` | Undefined token — unknown prefix; content duplicate | **0.80** | CRITICAL | Drop column; survivor of {FLAG1, FLAG2} renamed to `dG_cds_only` |
| 🔴 FLAG 3 | `dG_junction` | Zero-variance / possibly failed computation | **0.59** | HIGH | Verify junction sequence design intent; recompute if error |
| 🟡 FLAG 4 | `dG_*` columns | Temporal invariance (expected but verify provenance) | **0.06** | LOW | Note only; confirm single-timepoint computation is intentional |
| 🟡 FLAG 5 | `cai_std` | Duplicate value (likely coincidence) | **0.11** | LOW | No action required |
| 🟢 FLAG 6 | `fluor_per_od_*` | CV QC check | **—** | PASS | All bins pass; Low bin ~38% CV is acceptable |
| 🟢 FLAG 7 | `n_capillaries` | Event count QC check | **—** | PASS | All bins well above 10,000 threshold |
| 🟢 FLAG 8 | `cai_mean` | Range + monotonicity check | **—** | PASS | Positive biological signal confirmed |

---

## 4. CLEANED SCHEMA (POST-RESOLUTION)

After resolving FLAGS 1–3, the canonical feature matrix for Learn-phase regression should be:

| Column | Type | Status | Role in Model |
|---|---|---|---|
| `bin` | categorical | ✅ Clean | Target / stratification variable |
| `timepoint_h` | integer | ✅ Clean | Covariate |
| `n_capillaries` | integer | ✅ Clean | Weight / QC covariate |
| `cai_mean` | float | ✅ Clean | **Primary predictor** |
| `cai_std` | float | ✅ Clean | Uncertainty covariate |
| `fluor_per_od_mean` | float | ✅ Clean | **Primary response variable** |
| `fluor_per_od_std` | float | ✅ Clean | Response uncertainty |
| `dG_cds_only` | float | ⚠️ Rename required | Predictor (after FLAGS 1+2 resolved) |
| `dG_junction` | float | ⚠️ Investigate | Exclude until FLAG 3 resolved |
| `dG_utr_cds30` | float | ✅ Clean | Predictor |

**Columns to DROP before model ingestion:** `dG_dG_cds_only` (replaced), `ra_dG_cds_only` (duplicate)

---

## 5. PRELIMINARY BIOLOGICAL SIGNALS FOR DESIGN PHASE FEEDBACK

> These observations are **descriptive only** given N=9 bin-aggregated rows; formal regression awaits per-construct data.

### 5.1 Expression Kinetics

| bin | T=15 → T=25 Δ (%) | T=25 → T=35 Δ (%) | Trend |
|---|---|---|---|
| Low | +22.6% | +12.2% | Decelerating growth |
| Medium | +23.9% | +11.7% | Decelerating growth |
| High | +25.8% | +8.9% | Decelerating growth |

> Expression increases from T=15 to T=35 in all bins but the rate of increase slows — consistent with carbon source depletion or growth arrest at late timepoints in a closed batch system. High-bin constructs show strongest early accumulation.

### 5.2 CAI–Expression Gradient

```
CAI gradient across bins: Δ(High − Low) ≈ +0.046–0.052 CAI units
Fluorescence gradient:    Δ(High − Low) ≈ +284 to +390 RFU/OD across timepoints
```

A monotone positive CAI → fluorescence relationship is present at all timepoints. **Recommend CAI as primary Design-phase optimization lever in Cycle 2.**

### 5.3 Design Phase Recommendations

| Recommendation | Basis |
|---|---|
| Target CAI > 0.76 in next construct batch | High-bin CAI centroid is 0.758–0.761; push upper tail |
| Fix optimal measurement timepoint at T=25 h | Best signal-to-noise before deceleration; reduces experiment cost by eliminating T=35 if confirmed |
| Redesign junction sequences with ΔG variation | FLAG 3: zero variance in `dG_junction` prevents learning its contribution; introduce 3–5 distinct junction variants |
| Resolve `dG_cds_only` pipeline naming bug | FLAGS 1+2: pipeline must be patched before Cycle 2 data ingestion |
| Expand Low-bin construct sequencing | Low-bin CV (~38%) is highest; possible mixed-quality constructs; sequence-confirm all Low-bin members |

---

## 6. OPEN CLARIFICATION REQUESTS

The following questions must be answered by the Design/Build team before Cycle 2 begins:

| # | Question | Flag | Urgency |
|---|---|---|---|
| Q1 | Is the SRT–mCherry junction sequence **identical** across all library constructs by design? | FLAG 3 | HIGH |
| Q2 | What pipeline step generates the `dG_` prefix on column names? Is it a wrapper script applying a prefix to all RNAfold outputs? | FLAGS 1+2 | HIGH |
| Q3 | Was `dG_junction` computed per-construct and then averaged into bins, or was only one representative sequence folded? | FLAG 3 | HIGH |
| Q4 | Is `ra_` a known prefix in the RNAfold analysis wrapper used (e.g., does the tool output `ra_dG_cds_only` natively)? | FLAG 2 | MEDIUM |
| Q5 | Should T=35 h be retained in Cycle 2 given the decelerating expression signal, or is the timepoint serving a secondary purpose (stability / toxicity readout)? | — | MEDIUM |

---

*Report generated: Learn Phase, DBTL Cycle 1. All findings are based on the 9-row bin-summary dataset provided inline. Per-construct resolution data are required for regression modelling in Cycle 2.*